SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

QuantumScape is experiencing heightened investor activity driven by a strategic partnership with Honda and growing anticipation surrounding the upcoming World Ducati Week, where the community expects potential updates on solid-state battery testing. While some investors remain skeptical about the timeline for commercial scale and the impact of insider stock sales, bullish sentiment is fueled by the company's progress in anode-free technology and its expansion into high-growth sectors like AI data center power.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJT is currently trending as community discourse intensifies over reports regarding Donald Trump's significant financial gains from crypto and stock trading during his presidency. Supporters and critics remain deeply divided, with discussions centering on political loyalty, accusations of market manipulation, and the broader implications of his administration's policies on national and economic affairs.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is experiencing a significant surge, fueled by momentum from successful clinical data for its subcutaneous Briumvi treatment and growing speculation regarding a potential buyout as institutional interest climbs. The community is actively discussing the stock's transition toward record levels, often highlighting the significant short position and the potential for a squeeze as investor confidence in the company's long-term revenue growth intensifies.

ProShares Trust - ProShares UltraPro QQQ 3x Shares

ProShares UltraPro QQQ

TQQQ is experiencing intense volatility and downward pressure as investors rotate out of semiconductor and tech holdings due to escalating geopolitical tensions in the Middle East and concerns over stretched AI valuations. The community is actively debating whether current price levels represent a high-conviction discount buying opportunity or a deeper correction for this leveraged ETF.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending as investors react to the newly scheduled FDA Advisory Committee meeting for its lead DMD candidate, Deramiocel, alongside the release of positive five-year study data. While some community members view the meeting as a potential hurdle, many bulls interpret the public forum as a strategic opportunity to solidify a broad label approval ahead of the PDUFA date.

GE Vernova, Inc. engages in the electric power industry. It operates through the following segments: Power, Wind, and Electrification. The Power segment offers design, manufacture, and servicing gas, nuclear, hydro, and steam technologies, providing a critical foundation of dispatchable, flexible, stable, and reliable power. The Wind segment manages wind generation technologies, including onshore and offshore wind turbines and blades. The Electrification segment refers to the grid solutions, power conversion, electrification software, and solar and storage solutions technologies required for the transmission, distribution, conversion, storage, and orchestration of electricity from point of generation to point of consumption. The company was founded November 9, 2021 and is headquartered in Cambridge, MA.

GE Vernova Inc.

GE Vernova is surging as strong electrification demand and a massive order backlog fuel investor confidence in its role as a critical power infrastructure provider for AI data centers. The stock is seeing significant institutional interest and positive momentum following strong earnings, with market participants closely monitoring its strategic positioning in the grid modernization cycle.

REGENXBIO, Inc. is a clinical-stage biotechnology company, which engages in the development, commercialization, and licensing of recombinant adeno-associated virus gene therapy. Its product candidates include the NAV Technology Platform, which consists of exclusive rights to novel adeno-associated viral vectors, and therapeutic programs such as RGX-314, RGX-202, RGX-121, RGX-111, RGX-181, and RGX-381. The company was founded by Kenneth T. Mills and James M. Wilson on July 16, 2008 and is headquartered in Rockville, MD.

Regenxbio Inc

Regenxbio is trending as investors weigh strong pivotal trial results for its Duchenne muscular dystrophy gene therapy against regulatory uncertainty and recent financial challenges. The community is actively discussing the company's long-term potential, the impact of recent clinical holds, and the market implications of its current cash runway.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is facing significant selling pressure as investors await the upcoming AGM for concrete execution updates and clarity on production scaling. While the community remains polarized by the stock's recent volatility, many continue to debate the company's long-term potential as a key player in photonics and AI infrastructure despite the current lack of widespread institutional revenue confirmation.

ASML Holding NV engages in the development, production, marketing, sales, upgrading and servicing of advanced semiconductor equipment systems. It includes lithography, metrology and inspection systems. The company was founded on April 1, 1984 and is headquartered in Veldhoven, the Netherlands.

ASML Holding NV - New York Shares

ASML Holding NV

ASML is seeing significant market chatter as shares react to news that TSMC plans to delay the mass-market adoption of its most expensive high-NA EUV lithography machines until 2029 to manage costs. Despite this near-term pressure, the community remains intensely focused on the stock's role as a structural bottleneck in the global semiconductor buildout, with long-term investors viewing the dip as a strategic opportunity given the company's EUV monopoly and deep backlog.

Litecoin is a decentralized, peer-to-peer digital currency designed to enable instant, near-zero cost payments to individuals and merchants worldwide. As an open-source global payment network that functions independently of central banks or intermediaries, its main value proposition lies in providing a scarce digital asset with a fixed maximum supply of 84 million tokens.  The network operates using a Proof of Work mechanism where computers solve complex puzzles to confirm transactions and secure the blockchain. It is distinguished by a block generation time of 2.5 minutes, which allows for faster transaction confirmations and a higher total throughput than earlier protocols. Key technical features include the Scrypt hashing algorithm, which promotes wider network participation, and MimbleWimble Extension Blocks, which improve user privacy by allowing transaction details to be hidden.  The LTC token is used for settling global payments, executing microtransactions through smaller units called litoshis, and diversifying digital portfolios with a highly liquid asset. New tokens are issued to miners as rewards for verifying blocks, though these rewards undergo a halving event approximately every four years to strictly control inflation. This process ensures the ledger maintains immutability, meaning records cannot be changed once they are saved to the global network.  Created by former Google engineer Charlie Lee, the project is supported by the Litecoin Foundation, a non-profit organization dedicated to ecosystem adoption. Unlike many venture-backed projects, it is maintained by a decentralized community of independent developers and a global network of miners. The project has seen recent institutional adoption, with entities like Lite Strategy and Luxxfolio Holdings adding significant amounts of LTC to their corporate treasuries as of late 2025.

Litecoin

Litecoin is currently facing high volatility and intense community debate as it trades near historical lows, with market participants closely monitoring technical support levels and potential catalysts like Layer 2 testnet activity. While some traders are aggressively shorting the asset citing bearish trends, many investors remain focused on long-term accumulation, anticipating a significant reversal driven by the project's network utility and upcoming market cycles.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


8Usinnet

8Us